Hikma Pharmaceuticals (HIK.LSE) Q3 2026 Earnings

Aug 6Confirmed
Q1 2025
Q3 2025
Q1 2026
Q3 2026
79.75
84.39
89.02
93.65

Details

Expected EPS
81.7608
Actual EPS
93.65328000000001
Surprise EPS
11.89
Surprise Percent
+14.55%

Description

⁨Hikma Pharmaceuticals⁩ (⁦HIK.LSE⁩) has reported earnings of ⁦93.65328000000001⁩ per share for ⁦Q3 2026⁩.

0 Comments

Share your thoughts